# Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-efficacy-and-pharmacokinetics-of-shr-a1811-a-human-epidermal-growth/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Herui Yao,Min Yan,Zhongsheng Tong,Xinhong Wu,Min‐Hee Ryu,John Park,Jee Hyun Kim,Yahua Zhong,Yiming Zhao,Mark Voskoboynik,Yongmei Yin,Kan Liu,Andreas Kaubisch,Caigang Liu,Jian Zhang,Shouman Wang,Seock‐Ah Im,Vinod Ganju,Minal Barve,Hui Li,Changsheng Ye,Amitesh Roy,Li‐Yuan Bai,Chia-Jui Yen,Shanzhi Gu,Yung‐Chang Lin,Lingying Wu,Lequn Bao,Kaijing Zhao,Yu Shen,Shangyi Rong,Xiaoyu Zhu,Erwei Song |
| Citations | 47 |
| DOI | 10.1200/jco.23.02044 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4399872764 |
| PMID | 38900984 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Yiming Zhao](https://scholariq.org/researchers/yiming-zhao/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.